Hasil Pencarian - Filip Janku

Perbaiki Hasil
  1. 1
    Deciding site of biopsy at metastatic relapse: reply

    Deciding site of biopsy at metastatic relapse: reply oleh Filip Janku

    Diterbitkan 2014-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Tumor heterogeneity in the clinic: is it a real problem?

    Tumor heterogeneity in the clinic: is it a real problem? oleh Filip Janku

    Diterbitkan 2014-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    ALK fusions in the pan-cancer setting: another tumor-agnostic target?

    ALK fusions in the pan-cancer setting: another tumor-agnostic target? oleh Aditya Shreenivas, Filip Janku, Mohamed A. Gouda, Hui-Zi Chen, Ben George, Shumei Kato, Razelle Kurzrock

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study

    382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study oleh Filip Janku, Apostolia Tsimberidou, Diane Healey, Vincent O’Neill, Veronica Holley, Abha Adat, Ozgur Karakuzu, Greg Call, Gabriele Urschel

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    BRAF mutations in advanced cancers: clinical characteristics and outcomes.

    BRAF mutations in advanced cancers: clinical characteristics and outcomes. oleh Hazem El-Osta, Gerald Falchook, Apostolia Tsimberidou, David Hong, Aung Naing, Kevin Kim, Sijin Wen, Filip Janku, Razelle Kurzrock

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastatic solid tumors

    418 A phase 1, dose escalation and dose expansion study of SQZ PBMC HPV as monotherapy and in combination with atezolizumab in HLA-A*02+ Patients with HPV16+ recurrent, or metastat... oleh Filip Janku, Matthew Taylor, Michael Gordon, Cathy Eng, Antonio Jimeno, Joaquina Baranda, Ursula Matulonis, Martin Kornacker, Asha Kamat, Oliver Rosen

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors.

    Novel secondary somatic mutations in Ewing's sarcoma and desmoplastic small round cell tumors. oleh Yunyun Jiang, Vivek Subbiah, Filip Janku, Joseph A Ludwig, Aung Naing, Robert S Benjamin, Robert E Brown, Pete Anderson, Razelle Kurzrock

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    19 Exome-scale liquid biopsy characterization of emerging immune resistance mechanisms in treatment-resistant GIST

    19 Exome-scale liquid biopsy characterization of emerging immune resistance mechanisms in treatment-resistant GIST oleh Filip Janku, Josette Northcott, Sean Boyle, Richard Chen, Rachel Pyke, Charles Abbott, Eric Levy, Niamh Coleman, Fabio Navarro, Lee McDaniel

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    482 Phase1/2 study of an anti-galectin-9 antibody, LYT-200, in patients with metastatic solid tumors

    482 Phase1/2 study of an anti-galectin-9 antibody, LYT-200, in patients with metastatic solid tumors oleh Judy Wang, Filip Janku, Manish Sharma, Johanna Bendell, Amit Mahipal, George Dranitsaris, Aleksandra Filipovic, Zev Wainber, Joseph Bolen, Eric Elenko, Christopher Korth

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    500 SYNB1891, a bacterium engineered to produce a STING agonist, demonstrates target engagement in humans following intratumoral injection

    500 SYNB1891, a bacterium engineered to produce a STING agonist, demonstrates target engagement in humans following intratumoral injection oleh Filip Janku, Jason Luke, Sarina Piha-Paul, Karl Lewis, James Strauss, Mary Varterasian, Anna Sokolovska, Richard Riese, Michael Armstrong, Claire Verschraegen, Aoife Brennan

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers.

    PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancers. oleh Filip Janku, J Jack Lee, Apostolia M Tsimberidou, David S Hong, Aung Naing, Gerald S Falchook, Siqing Fu, Rajyalakshmi Luthra, Ignacio Garrido-Laguna, Razelle Kurzrock

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    397 Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: clinical trial experience at a tertiary care cancer center

    397 Intra-tumor immunotherapy injections utilizing image guidance in interventional radiology: clinical trial experience at a tertiary care cancer center oleh Sanjay Gupta, Vivek Subbiah, Sapna Patel, Adi Diab, Ravi Murthy, Aung Naing, Funda Meric-Bernstam, Filip Janku, Alda Tam, Timothy Yap, Rahul Sheth

    Diterbitkan 2020-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial

    Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial oleh Jeffrey A. How, Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha-Paul, Filip Janku, Bettzy Stephen, Aung Naing

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

    484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors oleh Stephane Champiat, Aurélien Marabelle, Aung Naing, Filip Janku, Patricia LoRusso, David Béchard, Elena Garralda, Vladimir Galvao, Peter Grell, Richard Sachse, Joachim Kiemle-Kallee

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors.

    KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. oleh Ignacio Garrido-Laguna, David S Hong, Filip Janku, Ly M Nguyen, Gerald S Falchook, Siqing Fu, Jenifer J Wheler, Rajyalakshmi Luthra, Aung Naing, Xuemei Wang, Razelle Kurzrock

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA

    A novel method for liquid-phase extraction of cell-free DNA for detection of circulating tumor DNA oleh Filip Janku, Helen J. Huang, David Y. Pereira, Masae Kobayashi, Chung Hei Chiu, S. Greg Call, Kristen T. Woodbury, Felix Chao, Daniel R. Marshak, Ricky Y. T. Chiu

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors

    Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors oleh Shuyang Yao, Filip Janku, Kimberly Koenig, Apostolia Maria Tsimberidou, Sarina Anne Piha‐Paul, Nai Shi, John Stewart, Amanda Johnston, John Bomalaski, Funda Meric‐Bernstam, Siqing Fu

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study oleh Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials

    Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials oleh Roman Groisberg, David S. Hong, Amini Behrang, Kenneth Hess, Filip Janku, Sarina Piha-Paul, Aung Naing, Siqing Fu, Robert Benjamin, Shreyaskumar Patel, Neeta Somaiah, Anthony Conley, Funda Meric-Bernstam, Vivek Subbiah

    Diterbitkan 2017-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma

    Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma oleh Jiri Polivka, Mohamed A. Gouda, Mahyar Sharif, Martin Pesta, Helen Huang, Inka Treskova, Vlastimil Woznica, Jindra Windrichova, Katerina Houfkova, Radek Kucera, Tomas Fikrle, Jan Ricar, Kristyna Pivovarcikova, Ondrej Topolcan, Filip Janku

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: